Publications

  1. Andersen N, Corradi J, Sine SM, Bouzat C. Stoichiometry for activation of neuronal alpha7 nicotinic receptors. Proc Natl Acad Sci U S A. 2013 Dec 17; 110(51):20819-24. Epub 2013 Dec 02.
    View PubMed
  2. Huang S, Li SX, Bren N, Cheng K, Gomoto R, Chen L, Sine SM. Complex between alpha-bungarotoxin and an alpha7 nicotinic receptor ligand-binding domain chimaera. Biochem J. 2013 Sep 1; 454(2):303-10.
    View PubMed
  3. Sine SM, Huang S, Li SX, daCosta CJ, Chen L. Inter-residue coupling contributes to high-affinity subtype-selective binding of alpha-bungarotoxin to nicotinic receptors. Biochem J. 2013 Sep 1; 454(2):311-21.
    View PubMed
  4. daCosta CJ, Sine SM. Stoichiometry for drug potentiation of a pentameric ion channel. Proc Natl Acad Sci U S A. 2013 Apr 16; 110(16):6595-600. Epub 2013 Apr 01.
    View PubMed
  5. Mukhtasimova N, Sine SM. Nicotinic receptor transduction zone: invariant arginine couples to multiple electron-rich residues. Biophys J. 2013 Jan 22; 104(2):355-67.
    View PubMed
  6. Engel AG, Shen XM, Selcen D, Sine S. New horizons for congenital myasthenic syndromes. Ann N Y Acad Sci. 2012 Dec; 1275:54-62.
    View PubMed
  7. Shen XM, Brengman JM, Edvardson S, Sine SM, Engel AG. Highly fatal fast-channel syndrome caused by AChR epsilon subunit mutation at the agonist binding site. Neurology. 2012 Jul 31; 79(5):449-54. Epub 2012 May 16.
    View PubMed
  8. Shen XM, Brengman JM, Sine SM, Engel AG. Myasthenic syndrome AChRalpha C-loop mutant disrupts initiation of channel gating. J Clin Invest. 2012 Jul 2; 122(7):2613-21. Epub 2012 Jun 25.
    View PubMed
  9. Sine SM. End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol Rev. 2012 Jul; 92(3):1189-234.
    View PubMed
  10. Wang HL, Cheng X, Sine SM. Intramembrane proton binding site linked to activation of bacterial pentameric ion channel. J Biol Chem. 2012 Feb 24; 287(9):6482-9. Epub 2011 Nov 14.
    View PubMed
  11. Li SX, Huang S, Bren N, Noridomi K, Dellisanti CD, Sine SM, Chen L. Ligand-binding domain of an alpha7-nicotinic receptor chimera and its complex with agonist. Nat Neurosci. 2011 Oct; 14(10):1253-9. Epub 2011 Sep 11.
    View PubMed
  12. daCosta CJ, Free CR, Corradi J, Bouzat C, Sine SM. Single-channel and structural foundations of neuronal alpha7 acetylcholine receptor potentiation. J Neurosci. 2011 Sep 28; 31(39):13870-9.
    View PubMed
  13. Andersen N, Corradi J, Bartos M, Sine SM, Bouzat C. Functional relationships between agonist binding sites and coupling regions of homomeric Cys-loop receptors. J Neurosci. 2011 Mar 9; 31(10):3662-9.
    View PubMed
  14. Wang HL, Sine SM. Function of the acetylcholine receptor at the atomic scale. Journal Of Computational And Theoretical Nanoscience. 2010 Dec; 7(12):2538-42.
  15. Engel AG, Shen XM, Selcen D, Sine SM. What have we learned from the congenital myasthenic syndromes. J Mol Neurosci. 2010 Jan; 40(1-2):143-53. Epub 2009 Aug 18.
    View PubMed
  16. Sine SM, Wang HL, Hansen S, Taylor P. On the origin of ion selectivity in the Cys-loop receptor family. J Mol Neurosci. 2010 Jan; 40(1-2):70-6.
    View PubMed
  17. Cheng X, Ivanov I, Wang H, Sine SM, McCammon JA. Molecular-dynamics simulations of ELIC-a prokaryotic homologue of the nicotinic acetylcholine receptor. Biophys J. 2009 Jun 3; 96(11):4502-13.
    View PubMed
  18. Mukhtasimova N, Lee WY, Wang HL, Sine SM. Detection and trapping of intermediate states priming nicotinic receptor channel opening. Nature. 2009 May 21; 459(7245):451-4. Epub 2009 Apr 01.
    View PubMed
  19. Rayes D, De Rosa MJ, Sine SM, Bouzat C. Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors. J Neurosci. 2009 May 6; 29(18):6022-32.
    View PubMed
  20. Wang HL, Toghraee R, Papke D, Cheng XL, McCammon JA, Ravaioli U, Sine SM. Single-channel current through nicotinic receptor produced by closure of binding site C-loop. Biophys J. 2009 May 6; 96(9):3582-90.
    View PubMed
  21. Lee WY, Free CR, Sine SM. Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2-M3 regions. J Neurosci. 2009 Mar 11; 29(10):3189-99.
    View PubMed
  22. Hansen SB, Wang HL, Taylor P, Sine SM. An ion selectivity filter in the extracellular domain of Cys-loop receptors reveals determinants for ion conductance. J Biol Chem. 2008 Dec 26; 283(52):36066-70. Epub 2008 Oct 21.
    View PubMed
  23. Lee WY, Free CR, Sine SM. Nicotinic receptor interloop proline anchors beta1-beta2 and Cys loops in coupling agonist binding to channel gating. J Gen Physiol. 2008 Aug; 132(2):265-78.
    View PubMed
  24. Wu TY, Smith CM, Sine SM, Levandoski MM. Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors. Mol Pharmacol. 2008 Aug; 74(2):466-75. Epub 2008 May 05.
    View PubMed
  25. Bouzat C, Bartos M, Corradi J, Sine SM. The interface between extracellular and transmembrane domains of homomeric Cys-loop receptors governs open-channel lifetime and rate of desensitization. J Neurosci. 2008 Jul 30; 28(31):7808-19.
    View PubMed
  26. Shen XM, Fukuda T, Ohno K, Sine SM, Engel AG. Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating. J Clin Invest. 2008 May; 118(5):1867-76.
    View PubMed
  27. Wang HL, Cheng X, Taylor P, McCammon JA, Sine SM. Control of cation permeation through the nicotinic receptor channel. PLoS Comput Biol. 2008 Feb; 4(2):e41.
    View PubMed
  28. Engel AG, Shen XM, Selcen D, Sine SM. Further observations in congenital myasthenic syndromes. Ann N Y Acad Sci. 2008; 1132:104-13.
    View PubMed
  29. Sine SM, Gao F, Lee WY, Mukhtasimova N, Wang HL, Engel AG. Recent structural and mechanistic insights into endplate acetylcholine receptors. Ann N Y Acad Sci. 2008; 1132:53-60.
    View PubMed
  30. Cheng X, Ivanov I, Wang H, Sine SM, McCammon JA. Nanosecond-timescale conformational dynamics of the human alpha7 nicotinic acetylcholine receptor. Biophys J. 2007 Oct 15; 93(8):2622-34. Epub 2007 Jun 15.
    View PubMed
  31. Ivanov I, Cheng X, Sine SM, McCammon JA. Barriers to ion translocation in cationic and anionic receptors from the Cys-loop family. J Am Chem Soc. 2007 Jul 4; 129(26):8217-24. Epub 2007 Jun 07.
    View PubMed
  32. Mukhtasimova N, Sine SM. An intersubunit trigger of channel gating in the muscle nicotinic receptor. J Neurosci. 2007 Apr 11; 27(15):4110-9.
    View PubMed
  33. Gao F, Mer G, Tonelli M, Hansen SB, Burghardt TP, Taylor P, Sine SM. Solution NMR of acetylcholine binding protein reveals agonist-mediated conformational change of the C-loop. Mol Pharmacol. 2006 Oct; 70(4):1230-5. Epub 2006 Jul 17.
    View PubMed
  34. Shen XM, Deymeer F, Sine SM, Engel AG. Slow-channel mutation in acetylcholine receptor alphaM4 domain and its efficient knockdown. Ann Neurol. 2006 Jul; 60(1):128-36.
    View PubMed
  35. Sine SM, Engel AG. Recent advances in Cys-loop receptor structure and function. Nature. 2006 Mar 23; 440(7083):448-55.
    View PubMed
  36. Cheng X, Wang H, Grant B, Sine SM, McCammon JA. Targeted molecular dynamics study of C-loop closure and channel gating in nicotinic receptors. PLoS Computational Biology. 2006; 2(9):1173-84.
    View PubMed
  37. Lee WY, Sine SM. Principal pathway coupling agonist binding to channel gating in nicotinic receptors. Nature. 2005 Nov 10; 438(7065):243-7.
    View PubMed
  38. Rayes D, Spitzmaul G, Sine SM, Bouzat C. Single-channel kinetic analysis of chimeric alpha 7-5HT(3A) receptors. Mol Pharmacol. 2005 Nov; 68(5):1475-83.
    View PubMed
  39. Mukhtasimova N, Free C, Sine SM. Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor. J Gen Physiol. 2005 Jul; 126(1):23-39. Epub 2005 Jun 13.
    View PubMed
  40. Engel AG, Sine SM. Current understanding of congenital myasthenic syndromes. Curr Opin Pharmacol. 2005 Jun; 5(3):308-21.
    View PubMed
  41. Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA. Ligand-induced conformational change in the alpha 7 nicotinic receptor ligand binding domain. Biophys J. 2005 Apr; 88(4):2564-76.
    View PubMed
  42. Gao F, Bren N, Burghardt TP, Hansen S, Henchman RH, Taylor P, McCammon JA, Sine SM. Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem. 2005 Mar 4; 280(9):8443-51. Epub 2004 Dec 09.
    View PubMed
  43. Shen XM, Ohno K, Sine SM, Engel AG. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker. Brain. 2005 Feb; 128(Part 2):345-55.
    View PubMed
  44. Pennington RA, Gao F, Sine SM, Prince RJ. Structural basis for epibatidine selectivity at desensitized nicotinic receptors. Mol Pharmacol. 2005 Jan; 67(1):123-31.
    View PubMed
  45. Ellison M, Gao F, Wang HL, Sine SM, Mclntosh JM, Olivera BM. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha 7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry. 2004 Dec 28; 43(51):16019-26.
    View PubMed
  46. Lee WY, Sine SM. Invariant aspartic Acid in muscle nicotinic receptor contributes selectively to the kinetics of agonist binding. J Gen Physiol. 2004 Nov; 124(5):555-67.
    View PubMed
  47. Bouzat C, Gumilar F, Spitzmaul G, Wang HL, Rayes D, Hansen SB, Taylor P, Sine SM. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature. 2004 Aug 19; 430(7002):896-900.
    View PubMed
  48. Sine SM, Wang HL, Gao F. Toward atomic-scale understanding of ligand recognition in the muscle nicotinic receptor. Curr Med Chem. 2004 Mar; 11(5):559-67.
    View PubMed
  49. Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA. Asymmetric structural motions of the homomeric alpha 7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys J. 2003 Nov 1; 85(5):3007-18.
    View PubMed
  50. Engel AG, Ohno K, Shen XM, Sine SM. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction. Ann N Y Acad Sci. 2003 Sep; 998:138-60.
    View PubMed
  51. Sine SM, Wang HL, Ohno K, Shen XM, Lee WY, Engel AG. Mechanistic diversity underlying fast channel congenital myasthenic syndromes. Ann N Y Acad Sci. 2003 Sep; 998:128-37.
    View PubMed
  52. Wang HL, Gao F, Bren N, Sine SM. Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain. J Biol Chem. 2003 Aug 22; 278(34):32284-91.
    View PubMed
  53. Gao F, Bern N, Little A, Wang HL, Hansen SB, Talley TT, Taylor P, Sine SM. Curariform antagonists bind in different orientations to acetylcholine-binding protein. J Biol Chem. 2003 Jun 20; 278(25):23020-6. Epub 2003 Apr 07.
    View PubMed
  54. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: a diverse array of molecular targets. J Neurocytol. 2003 Jun-Sep; 32(5-8):1017-37.
    View PubMed
  55. Engel AG, Ohno K, Sine SM. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat Rev Neurosci. 2003 May; 4(5):339-52.
    View PubMed
  56. Shen XM, Ohno K, Tsujino A, Brengman JM, Gingold M, Sine SM, Engel AG. Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating. J Clin Invest. 2003 Feb; 111(4):497-505.
    View PubMed
  57. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: progress over the past decade. Muscle Nerve. 2003 Jan; 27(1):4-25.
    View PubMed
  58. Sine SM. The nicotinic receptor ligand binding domain. J Neurobiol. 2002 Dec; 53(4):431-46.
    View PubMed
  59. Sine SM, Shen XM, Wang HL, Ohno K, Lee WY, Tsujino A, Brengmann J, Bren N, Vajsar J, Engel AG. Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating. J Gen Physiol. 2002 Oct; 120(4):483-96.
    View PubMed
  60. Engel AG, Ohno K, Sine SM. The spectrum of congenital myasthenic syndromes. Mol Neurobiol. 2002 Oct-Dec; 26(2-3):347-67.
    View PubMed
  61. Prince RJ, Pennington RA, Sine SM. Mechanism of tacrine block at adult human muscle nicotinic acetylcholine receptors. J Gen Physiol. 2002 Sep; 120(3):369-93.
    View PubMed
  62. Sine SM, Wang HL, Bren N. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain. J Biol Chem. 2002 Aug 9; 277(32):29210-23. Epub 2002 May 13.
    View PubMed
  63. Molles BE, Tsigelny I, Nguyen PD, Gao SX, Sine SM, Taylor P. Residues in the epsilon subunit of the nicotinic acetylcholine receptor interact to confer selectivity of waglerin-1 for the alpha-epsilon subunit interface site. Biochemistry. 2002 Jun 25; 41(25):7895-906.
    View PubMed
  64. Bouzat C, Gumilar F, Esandi MD, Sine SM. Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor. Biophys J. 2002 Apr; 82(4):1920-9.
    View PubMed
  65. Ibanez-Tallon I, Miwa JM, Wang HL, Adams NC, Crabtree GW, Sine SM, Heintz N. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron. 2002 Mar 14; 33(6):893-903.
    View PubMed
  66. Molles BE, Rezai P, Kline EF, McArdle JJ, Sine SM, Taylor P. Identification of residues at the alpha and epsilon subunit interfaces mediating species selectivity of Waglerin-1 for nicotinic acetylcholine receptors. J Biol Chem. 2002 Feb 15; 277(7):5433-40.
    View PubMed
  67. Malany S, Osaka H, Sine SM, Taylor P. Orientation of alpha-neurotoxin at the subunit interfaces of the nicotinic acetylcholine receptor. Biochemistry. 2000 Dec 19; 39(50):15388-98.
    View PubMed
  68. Wang HL, Ohno K, Milone M, Brengman JM, Evoli A, Batocchi AP, Middleton LT, Christodoulou K, Engel AG, Sine SM. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol. 2000 Sep; 116(3):449-62.
    View PubMed
  69. Grosman C, Salamone FN, Sine SM, Auerbach A. The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J Gen Physiol. 2000 Sep; 116(3):327-40.
    View PubMed
  70. Bouzat C, Barrantes F, Sine S. Nicotinic receptor fourth transmembrane domain: hydrogen bonding by conserved threonine contributes to channel gating kinetics. J Gen Physiol. 2000 May; 115(5):663-72.
    View PubMed
  71. Bren N, Sine SM. Hydrophobic pairwise interactions stabilize alpha-conotoxin MI in the muscle acetylcholine receptor binding site. J Biol Chem. 2000 Apr 28; 275(17):12692-700.
    View PubMed
  72. Osaka H, Malany S, Molles BE, Sine SM, Taylor P. Pairwise electrostatic interactions between alpha-neurotoxins and gamma, delta, and epsilon subunits of the nicotinic acetylcholine receptor. J Biol Chem. 2000 Feb 25; 275(8):5478-84.
    View PubMed
  73. Quiram PA, McIntosh JM, Sine SM. Pairwise interactions between neuronal alpha(7) acetylcholine receptors and alpha-conotoxin PnIB. J Biol Chem. 2000 Feb 18; 275(7):4889-96.
    View PubMed
  74. Quiram PA, Ohno K, Milone M, Patterson MC, Pruitt NJ, Brengman JM, Sine SM, Engel AG. Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. J Clin Invest. 1999 Nov; 104(10):1403-10.
    View PubMed
  75. Prince RJ, Sine SM. Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models. J Biol Chem. 1999 Jul 9; 274(28):19623-9.
    View PubMed
  76. Quiram PA, Jones JJ, Sine SM. Pairwise interactions between neuronal alpha7 acetylcholine receptors and alpha-conotoxin ImI. J Biol Chem. 1999 Jul 9; 274(28):19517-24.
    View PubMed
  77. Osaka H, Malany S, Kanter JR, Sine SM, Taylor P. Subunit interface selectivity of the alpha-neurotoxins for the nicotinic acetylcholine receptor. J Biol Chem. 1999 Apr 2; 274(14):9581-6.
    View PubMed
  78. Wang HL, Milone M, Ohno K, Shen XM, Tsujino A, Batocchi AP, Tonali P, Brengman J, Engel AG, Sine SM. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci. 1999 Mar; 2(3):226-33.
    View PubMed
  79. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: recent advances. Arch Neurol. 1999 Feb; 56(2):163-7.
    View PubMed
  80. Prince RJ, Sine SM. Epibatidine activates muscle acetylcholine receptors with unique site selectivity. Biophys J. 1998 Oct; 75(4):1817-27.
    View PubMed
  81. Engel AG, Ohno K, Milone M, Sine SM. Congenital myasthenic syndromes. New insights from molecular genetic and patch-clamp studies. Ann N Y Acad Sci. 1998 May 13; 841:140-56.
    View PubMed
  82. Quiram PA, Sine SM. Identification of residues in the neuronal alpha7 acetylcholine receptor that confer selectivity for conotoxin ImI. J Biol Chem. 1998 May 1; 273(18):11001-6.
    View PubMed
  83. Quiram PA, Sine SM. Structural elements in alpha-conotoxin IMI essential for binding to neuronal alpha(7) receptors. J Biol Chem. 1998 May 1; 273(18):11007-11.
    View PubMed
  84. Prince RJ, Sine SM. Epibatidine binds with unique site and state selectivity to muscle nicotinic acetylcholine receptors. J Biol Chem. 1998 Apr 3; 273(14):7843-9.
    View PubMed
  85. Taylor P, Osaka H, Molles BE, Sugiyama N, Marchot P, Ackermann EJ, Malany S, McArdle JJ, Sine SM, Tsigelny I. Toxins selective for subunit interfaces as probes of nicotinic acetylcholine receptor structure. J Physiol Paris. 1998 Apr; 92(2):79-83.
    View PubMed
  86. Sine SM, Bren N, Quiram PA. Molecular dissection of subunit interfaces in the nicotinic acetylcholine receptor. J Physiol Paris. 1998 Apr; 92(2):101-5.
    View PubMed
  87. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: experiments of nature. J Physiol Paris. 1998 Apr; 92(2):113-7.
    View PubMed
  88. Sugiyama N, Marchot P, Kawanishi C, Osaka H, Molles B, Sine SM, Taylor P. Residues at the subunit interfaces of the nicotinic acetylcholine receptor that contribute to alpha-conotoxin M1 binding. Mol Pharmacol. 1998 Apr; 53(4):787-94.
    View PubMed
  89. Milone M, Wang HL, Ohno K, Prince R, Fukudome T, Shen XM, Brengman JM, Griggs RC, Sine SM, Engel AG. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit. Neuron. 1998 Mar; 20(3):575-88.
    View PubMed
  90. Engel AG, Ohno K, Wang HL, Milone M, Sine SM. Molecular basis of congenital myasthenic syndromes: mutations in the acetylcholine receptor. Neuroscientist. 1998; 4(3):185-94.
  91. Bren N, Sine SM. Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists. J Biol Chem. 1997 Dec 5; 272(49):30793-8.
    View PubMed
  92. Sine SM. Identification of equivalent residues in the gamma, delta, and epsilon subunits of the nicotinic receptor that contribute to alpha-bungarotoxin binding. J Biol Chem. 1997 Sep 19; 272(38):23521-7.
    View PubMed
  93. Milone M, Wang HL, Ohno K, Fukudome T, Pruitt JN, Bren N, Sine SM, Engel AG. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci. 1997 Aug 1; 17(15):5651-65.
    View PubMed
  94. Tsigelny I, Sugiyama N, Sine SM, Taylor P. A model of the nicotinic receptor extracellular domain based on sequence identity and residue location. Biophys J. 1997 Jul; 73(1):52-66.
    View PubMed
  95. Wang HL, Auerbach A, Bren N, Ohno K, Engel AG, Sine SM. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol. 1997 Jun; 109(6):757-66.
    View PubMed
  96. Ohno K, Quiram PA, Milone M, Wang HL, Harper MC, Pruitt JN 2nd, Brengman JM, Pao L, Fischbeck KH, Crawford TO, Sine SM, Engel AG. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet. 1997 May; 6(5):753-66.
    View PubMed
  97. Engel AG, Ohno K, Milone M, Sine SM. Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes. Neurology. 1997; 48(4 Suppl 5):S28-35.
  98. Fu DX, Sine SM. Asymmetric contribution of the conserved disulfide loop to subunit oligomerization and assembly of the nicotinic acetylcholine receptor. J Biol Chem. 1996 Dec 6; 271(49):31479-84.
    View PubMed
  99. Engel AG, Ohno K, Bouzat C, Sine SM, Griggs RC. End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann Neurol. 1996 Nov; 40(5):810-7.
    View PubMed
  100. Prince RJ, Sine SM. Molecular dissection of subunit interfaces in the acetylcholine receptor. Identification of residues that determine agonist selectivity. J Biol Chem. 1996 Oct 18; 271(42):25770-7.
    View PubMed
  101. Akk G, Sine S, Auerbach A. Binding sites contribute unequally to the gating of mouse nicotinic alpha D200N acetylcholine receptors. J Physiol (Lond) 1996 Oct 1; 496(Pt 1):185-96.
    View PubMed
  102. Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, Pruitt JN 2nd, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet. 1996 Sep; 5(9):1217-27.
    View PubMed
  103. Ohno K, Wang HL, Milone M, Bren N, Brengman JM, Nakano S, Quiram P, Pruitt JN, Sine SM, Engel AG. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron. 1996 Jul; 17(1):157-70.
    View PubMed
  104. Chen J, Zhang Y, Akk G, Sine S, Auerbach A. Activation kinetics of recombinant mouse nicotinic acetylcholine receptors: mutations of alpha-subunit tyrosine 190 affect both binding and gating. Biophys J. 1995 Sep; 69(3):849-59.
    View PubMed
  105. Sine SM, Kreienkamp HJ, Bren N, Maeda R, Taylor P. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity. Neuron. 1995 Jul; 15(1):205-11.
    View PubMed
  106. Sine SM, Ohno K, Bouzat C, Auerbach A, Milone M, Pruitt JN, Engel AG. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron. 1995 Jul; 15(1):229-39.
    View PubMed
  107. Kreienkamp HJ, Maeda RK, Sine SM, Taylor P. Intersubunit contacts governing assembly of the mammalian nicotinic acetylcholine receptor. Neuron. 1995 Mar; 14(3):635-44.
    View PubMed
  108. Ohno K, Hutchinson DO, Milone M, Brengman JM, Bouzat C, Sine SM, Engel AG. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A. 1995 Jan 31; 92(3):758-62.
    View PubMed
  109. Bouzat C, Bren N, Sine SM. Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron. 1994 Dec; 13(6):1395-402.
    View PubMed
  110. Fu DX, Sine SM. Competitive antagonists bridge the alpha-gamma subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions. J Biol Chem. 1994 Oct 21; 269(42):26152-7.
    View PubMed
  111. Sine SM, Quiram P, Papanikolaou F, Kreienkamp HJ, Taylor P. Conserved tyrosines in the alpha subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists. J Biol Chem. 1994 Mar 25; 269(12):8808-16.
    View PubMed
  112. Kreienkamp HJ, Sine SM, Maeda RK, Taylor P. Glycosylation sites selectively interfere with alpha-toxin binding to the nicotinic acetylcholine receptor. J Biol Chem. 1994 Mar 18; 269(11):8108-14.
    View PubMed
  113. Sine SM. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity. Proc Natl Acad Sci U S A. 1993 Oct 15; 90(20):9436-40.
    View PubMed
  114. Sine SM, Claudio T. Gamma- and delta-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J Biol Chem. 1991 Oct 15; 266(29):19369-77.
    View PubMed
  115. Sine SM, Claudio T. Stable expression of the mouse nicotinic acetylcholine receptor in mouse fibroblasts. Comparison of receptors in native and transfected cells. J Biol Chem. 1991 Jul 25; 266(21):13679-89.
    View PubMed
  116. Sine SM, Claudio T, Sigworth FJ. Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts. Single channel current kinetics reveal distinct agonist binding affinities. J Gen Physiol. 1990 Aug; 96(2):395-437.
    View PubMed
  117. Sine SM. Functional properties of human skeletal muscle acetylcholine receptors expressed by the TE671 cell line. J Biol Chem. 1988 Dec 5; 263(34):18052-62.
    View PubMed
  118. Claudio T, Green WN, Hartman DS, Hayden D, Paulson HL, Sigworth FJ, Sine SM, Swedlund A. Genetic reconstitution of functional acetylcholine receptor channels in mouse fibroblasts. Science. 1987 Dec 18; 238(4834):1688-94.
    View PubMed
  119. Sigworth FJ, Sine SM. Data transformations for improved display and fitting of single-channel dwell time histograms. Biophys J. 1987 Dec; 52(6):1047-54.
    View PubMed
  120. Sine SM, Steinbach JH. Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by high concentrations of agonist. J Physiol (Lond) 1987 Apr; 385:325-59.
    View PubMed
  121. Sine SM, Steinbach JH. Acetylcholine receptor activation by a site-selective ligand: nature of brief open and closed states in BC3H-1 cells. J Physiol (Lond) 1986 Jan; 370:357-79.
    View PubMed
  122. Sine SM, Steinbach JH. Activation of acetylcholine receptors by low concentrations of agonist. J Physiol. 1986; 373:129-62.
    View PubMed
  123. Sine SM, Steinbach JH. Agonists block currents through acetylcholine receptor channels. Biophys J. 1984 Aug; 46(2):277-83.
    View PubMed
  124. Sine SM, Steinbach JH. Activation of a nicotinic acetylcholine receptor. Biophys J. 1984 Jan; 45(1):175-85.
    View PubMed
  125. Sine SM, Taylor P. Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem. 1982 Jul 25; 257(14):8106-4.
    View PubMed
  126. Taylor P, Sine SM. Ligand occupation and the functional states of nicotinic receptor. Trends Pharmacol Sci. 1982; 3:197-200.
  127. Sine SM, Taylor P. Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem. 1981 Jul 10; 256(13):6692-9.
    View PubMed
  128. Sine SM, Taylor P. The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J Biol Chem. 1980 Nov 10; 255(21):10144-56.
    View PubMed
  129. Taylor P, Weiland G, Sine SM, Chignell C, Brown R. Cholinergic receptor state transitions and local anesthetic action. Prog Anesthesiol. 1980; 2:175-88.
  130. Sine S, Taylor P. Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells. J Biol Chem. 1979 May 10; 254(9):3315-25.
    View PubMed
  131. Sine SM, Conklin TE, Okamura WH. Studies on vitamin D and its analogs. VI. 3-deoxy-A-homovitamin D3, a model synthesis. J Org Chem. 1974 Dec 13; 39(25):3797-9.
    View PubMed
  132. Wing RM, Okamura WH, Pirio MR, Sine SM, Norman AW. Vitamin D in solution: conformations of vitamin D3, 1alpha,25-dihydroxyvitamin D3, and dihydrotachysterol3. Science. 1974 Dec 6; 186(4167):939-41.
    View PubMed